Ci Investments Inc. Biomarin Pharmaceutical Inc Transaction History

Ci Investments Inc.

$23.7 Billion
Q1 2025

A detailed history of Ci Investments Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ci Investments Inc. holds 3,666 shares of BMRN stock, worth $213,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,666

Previous 5,576 34.25%

Holding current value

$213,031

Previous $367,000 29.43%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$61.25 - $72.83 $116,987 - $139,105	-1,910 Reduced 34.25%	3,666 $259,000
Q4 2024 Feb 12, 2025	BUY	$61.93 - $70.49 $51,525 - $58,647	832 Added 17.54%	5,576 $367,000
Q3 2024 Nov 12, 2024	SELL	$69.02 - $93.84 $14,977 - $20,363	-217 Reduced 4.37%	4,744 $333,000
Q2 2024 Aug 12, 2024	SELL	$74.43 - $92.22 $32,079 - $39,746	-431 Reduced 7.99%	4,961 $408,000
Q1 2024 May 13, 2024	BUY	$83.81 - $99.0 $192,595 - $227,502	2,298 Added 74.27%	5,392 $471,000
Q4 2023 Feb 12, 2024	SELL	$76.22 - $98.51 $39,253 - $50,732	-515 Reduced 14.27%	3,094 $298,000
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $41,599 - $46,200	-489 Reduced 11.93%	3,609 $319,000
Q2 2023 Aug 11, 2023	SELL	$86.68 - $100.3 $27,997 - $32,396	-323 Reduced 7.31%	4,098 $355,000
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $117,045 - $156,438	1,334 Added 43.21%	4,421 $430,000
Q4 2022 Feb 10, 2023	SELL	$80.93 - $108.63 $10,439 - $14,013	-129 Reduced 4.01%	3,087 $319,000
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $18,157 - $21,423	221 Added 7.38%	3,216 $273,000
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $55,968 - $68,003	-783 Reduced 20.73%	2,995 $248,000
Q1 2022 May 12, 2022	SELL	$74.28 - $92.69 $28,077 - $35,036	-378 Reduced 9.1%	3,778 $291,000
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $11,977 - $15,275	167 Added 4.19%	4,156 $367,000
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $80,452 - $91,965	1,076 Added 36.94%	3,989 $308,000
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $90,838 - $102,002	-1,203 Reduced 29.23%	2,913 $243,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $89,152 - $108,193	1,193 Added 40.81%	4,116 $311,000
Q4 2020 Feb 09, 2021	BUY	$72.61 - $90.2 $77,257 - $95,972	1,064 Added 57.24%	2,923 $256,000
Q3 2020 Nov 09, 2020	BUY	$71.87 - $131.03 $33,635 - $61,322	468 Added 33.64%	1,859 $141,000
Q2 2020 Aug 07, 2020	BUY	$79.55 - $124.22 $18,296 - $28,570	230 Added 19.81%	1,391 $172,000
Q1 2020 Aug 07, 2020	BUY	$71.37 - $96.85 $27,191 - $36,899	381 Added 48.85%	1,161 $98,000
Q4 2019 Feb 11, 2020	BUY	$64.27 - $86.37 $44,860 - $60,286	698 Added 851.22%	780 $66,000
Q3 2019 Nov 08, 2019	BUY	$67.4 - $85.11 $5,526 - $6,979	82 New	82 $6,000

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

184M

Call Options Held

1.24M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.

Account

Ci Investments Inc. Biomarin Pharmaceutical Inc Transaction History